Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pulmatrix (PULM) EPS (Weighted Average and Diluted) (2022 - 2025)

Pulmatrix (PULM) has disclosed EPS (Weighted Average and Diluted) for 4 consecutive years, with -$0.25 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 54.55% to -$0.25 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.41 through Dec 2025, up 84.35% year-over-year, with the annual reading at -$1.41 for FY2025, 46.18% up from the prior year.
  • EPS (Weighted Average and Diluted) hit -$0.25 in Q4 2025 for Pulmatrix, down from -$0.24 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.5 in Q1 2025 to a low of -$1.59 in Q2 2024.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.72 across 4 years, with a median of -$0.71 in 2024.
  • Biggest YoY gain for EPS (Weighted Average and Diluted) was 118.85% in 2024; the steepest drop was 52.88% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$1.14 in 2022, then soared by 50.0% to -$0.57 in 2023, then grew by 3.51% to -$0.55 in 2024, then soared by 54.55% to -$0.25 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for PULM at -$0.25 in Q4 2025, -$0.24 in Q3 2025, and -$0.42 in Q2 2025.